Literature DB >> 5653873

Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.

N C Nevin, J Slack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5653873      PMCID： PMC1468606          DOI： 10.1136/jmg.5.1.9

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  12 in total

1.  THE INHERITANCE OF ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA.

Authors:  A K KHACHADURIAN
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

2.  A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.

Authors:  D S FREDRICKSON; R S LEES
Journal:  Circulation       Date:  1965-03       Impact factor: 29.690

3.  Micromethod for the direct determination of serum triglycerides.

Authors:  E VAN HANDEL; D B ZILVERSMIT
Journal:  J Lab Clin Med       Date:  1957-07

4.  The genetic aspects of atherosclerosis.

Authors:  E O WHEELER
Journal:  Am J Med       Date:  1957-10       Impact factor: 4.965

5.  Hereditary hypercholesterolaemic xanthomatosis.

Authors:  J C LEONARD
Journal:  Lancet       Date:  1956-12-15       Impact factor: 79.321

6.  Essential familial hypercholesterolemia and xanthomatosis; follow-up study of twelve Danish families.

Authors:  J PIPER; L ORRILD
Journal:  Am J Med       Date:  1956-07       Impact factor: 4.965

7.  Hypercholesteremia with predisposition to atherosclerosis, an inborn error of lipid metabolism.

Authors:  D ADLERSBERG
Journal:  Am J Med       Date:  1951-11       Impact factor: 4.965

8.  Simple tests for bimodality and bitangentiality.

Authors:  J B S HALDANE
Journal:  Ann Eugen       Date:  1952-05

Review 9.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-26       Impact factor: 91.245

10.  Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis.

Authors:  J Slack; N C Nevin
Journal:  J Med Genet       Date:  1968-03       Impact factor: 6.318
View more
  7 in total

1.  Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype.

Authors:  K K Namboodiri; R C Elston; C J Glueck; R Fallat; C R Buncher; R Tsang
Journal:  Am J Hum Genet       Date:  1975-07       Impact factor: 11.025

2.  Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection.

Authors:  J L Goldstein; M J Harrod; M S Brown
Journal:  Am J Hum Genet       Date:  1974-03       Impact factor: 11.025

3.  Estimation of environmental and genetic components of quantitative traits with application to serum cholesterol levels.

Authors:  J M Simpson; P J Brennan; C A McGilchrist; R B Blacket
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

4.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

Authors:  J L Goldstein; H G Schrott; W R Hazzard; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

5.  Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.

Authors:  J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

6.  Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis.

Authors:  J Slack; N C Nevin
Journal:  J Med Genet       Date:  1968-03       Impact factor: 6.318

7.  Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

Authors:  P O Kwiterovich; D S Fredrickson; R I Levy
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.